Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma

Guiquan Jia, Ashley Morando, Janet Jackman, Nirav Bhakta, John V. Fahy, Prescott G. Woodruff, Kelly Loyet, Tangsheng Yi, Joseph R. Arron
European Respiratory Journal 2015 46: PA3883; DOI: 10.1183/13993003.congress-2015.PA3883
Guiquan Jia
1ITGR Diagnostics Discovery, Genentech Inc., South San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Morando
4Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet Jackman
3Immunology, Genentech Inc., South San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nirav Bhakta
2Airway Clinical Research Center and General Clinical Research Center, University of California, San Francisco, San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John V. Fahy
2Airway Clinical Research Center and General Clinical Research Center, University of California, San Francisco, San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prescott G. Woodruff
2Airway Clinical Research Center and General Clinical Research Center, University of California, San Francisco, San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Loyet
4Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tangsheng Yi
3Immunology, Genentech Inc., South San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph R. Arron
1ITGR Diagnostics Discovery, Genentech Inc., South San Francisco, CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background: Tryptase, the major protein product of mast cells, can mediate multiple pathologic manifestations of asthma.

Objectives: Determine whether airway tryptase levels are related to manifestations of type 2 airway inflammation in asthma patients of varying severity.

Methods: Bronchoscopy in healthy controls (N=20), patients with mild-moderate asthma (N=23) before and after an 8-week course of inhaled corticosteroid (ICS) treatment, moderate asthma (N=33) on chronic ICS treatment, and severe asthma (N=64) uncontrolled despite high-dose ICS treatment. Assessments include: bronchoalveolar lavage (BAL) tryptase, bronchial epithelial gene expression, FeNO, and peripheral blood levels of eosinophils, periostin, tryptase, and IgE.

Results: In mild asthma patients not taking ICS, BAL but not plasma tryptase levels were significantly higher than in controls. BAL tryptase was significantly correlated with the expression of a bronchial epithelial “Th2 signature”, FeNO, blood eosinophils, and plasma periostin and IgE, but not with plasma tryptase levels. Mild asthma patients with elevated BAL tryptase at baseline exhibited significant decreases in BAL tryptase after ICS treatment. In moderate asthma patients on stable ICS doses and severe asthma patients uncontrolled despite high-dose ICS, BAL tryptase levels were elevated vs. healthy controls but were not strongly correlated with indices of type 2 airway inflammation.

Conclusions: BAL tryptase levels and measures of type 2 airway inflammation are concordant in mild asthma patients, but discordant in moderate and severe asthma patients, which may reflect different mast cell phenotypes, localization, and effects of steroid exposure.

  • Asthma - mechanism
  • Bronchoalveolar lavage
  • Inflammation
  • Copyright ©ERS 2015
Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Guiquan Jia, Ashley Morando, Janet Jackman, Nirav Bhakta, John V. Fahy, Prescott G. Woodruff, Kelly Loyet, Tangsheng Yi, Joseph R. Arron
European Respiratory Journal Sep 2015, 46 (suppl 59) PA3883; DOI: 10.1183/13993003.congress-2015.PA3883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Guiquan Jia, Ashley Morando, Janet Jackman, Nirav Bhakta, John V. Fahy, Prescott G. Woodruff, Kelly Loyet, Tangsheng Yi, Joseph R. Arron
European Respiratory Journal Sep 2015, 46 (suppl 59) PA3883; DOI: 10.1183/13993003.congress-2015.PA3883
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • DP2/CRTh2 is expressed by ASM cells in asthma and its inhibition suppresses ASM migration
  • Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes
  • Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease
Show more 3.2 Airway Cell Biology and Immunopathology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society